- Live market news
- Stocks
- BGMS
Cyclacel Pharmaceuticals, Inc.
BGMSStockUnited States
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow.
Latest news on BGMSranked by Oyticker for market impact
- 35Impact
Halper Sadeh initiates shareholder fairness investigations into BZH, CBAN, ATKR, BGMS
Law firm Halper Sadeh is investigating whether four companies are obtaining fair valuations for shareholders in potential transactions, citing possible insider benefit asymmetries.
CBANATKRBZHBGMSCapital MarketsLegal/Regulatory - 45Impact
M&A Class Action Investigation Initiated for ATKR, BZH, BGMS, CBAN
A securities class action firm has announced investigation into mergers involving four companies, signaling potential shareholder disputes over deal terms or disclosure adequacy.
CBANATKRBZHBGMSCapital Markets - 45Impact
Halper Sadeh initiates shareholder-protection investigations into BZH, LNTH, BGMS
Investor-rights law firm Halper Sadeh LLC has launched investigations into three companies for potential federal securities violations, typically signaling concerns over M&A fairness, disclosure adequacy or fiduciary duty breaches.
BZHBGMSLNTH
What BGMS filed
- 4 Nov 2026
- 16 Oct 2026
- 14 Aug 2026
- 13 Aug 2026
Investor communication
- 1 Jul 2026
- 22 Jun 2026
- 10 Jun 2026
Unregistered share sale
- 4 Jun 2026
Investor communication
- 15 May 2026
- 14 May 2026
Investor communication
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.